Division of Community HIV/AIDS Programs: RWC 2022 Business Day Meeting

HRSA's HIV/AIDS Bureau's Division of Community HIV/AIDS Programs (DCHAP) held a session for recipients.

• State of the Division of Community HIV/AIDS Programs (PDF)
  CAPT Mahyar Mofidi, DMD, PhD, Director
  Stephanie Yun, MPH, CHES, Deputy Director
  Recording not available

Sessions

• RWHAP Part D: Introduction to the Part D Basic Training Program
  This session is the first in a series of sessions for the RWHAP Part D Basic Training Program. During the session, RWHAP Parts D and C/D recipients will be provided an overview of the RWHAP Part D Basic Training Program and foundational knowledge of the RWHAP Part D legislation and legislative requirements to help successfully implement their Part D programs.
• Part F Dental Programs: Integration, Leveraging Resources, and Updates (PDF)
  This workshop will foster an exchange of knowledge, best practices, and experiences across Community-Based Dental Partnership Program (CBDPP) grant recipients.
  Recording not available
• Imposition of Charges: Schedule of Charges and Cap on Charges
  During this session, participants will learn about the RWHAP statutory requirements and programmatic guidance pertaining to the imposition of charges on clients for services, the schedule of charges, nominal charges, sliding fee scale, and caps on charges.
• Clinical Quality Management (CQM): Best Practices, Implementation, and Development
  Two presentations:
  • Process Development for Meaningful Quality Improvement (Laurali Riley-Senior Program Manager, Ryan White Part C Clinic
    Alaska Native Tribal Health Consortium)
  • Utilizing Data to Inform Clinical Quality Management Best Practices and Quality Improvement Interventions (Harold Glenn San Agustin, MD, AAHIVS, HIV Medical Director, JWCH Institute, Inc., Los Angeles, CA)
• A Community Health Center in the Rural Southeast’s Experiences with Linkage and Retention Since the COVID-19 Pandemic
  Highlighting best practices for engaging priority populations; specifically, gay, bisexual, and other men who have sex with men, in particular Black, Latino, and American Indian/Alaska Native men; Black women; transgender women; youth aged 13–24 years; and people who inject drugs post the COVID-19 pandemic.